skip to main content

Research + Education

The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.


  • How to make cancer prevention more equitable

    Programs and services aimed at helping people reduce their risk of cancer don’t always meet the needs of people from diverse communities and cultures.
    Read More >
  • Improving cancer health equity involves everyone

    Equity in cancer care has long been an important theme for Lori Pierce, M.D. She made it a focus as president of the American Society of Clinical Oncology in 2021. So when the editors of The Cancer Journal selected health equity in cancer care as the topic for a recent special issue, Pierce, professor of radiation oncology at Michigan Medicine, was the ideal choice for guest editor.
    Read More >
  • Reenergizing hospital staff through interactive recharge rooms

    Recently, Michigan Medicine became the first health care system in the Midwest to bring Recharge Rooms to its employees. These innovative, immersive mental health interventions were designed to support the well-being and resilience of the hospital’s health care workers.
    Read More >
  • Why does cancer immunotherapy cause colitis in some patients?

    Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. They also found a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.
    Read More >